Health ❯ Clinical Research ❯ Drug Development

Clinical Trials

Efficacy Studies Phase 3 Trials Semaglutide Studies Oral Medications Antibiotic Efficacy Pharmacokinetics Mycological Cure Therapeutics Toxicology Oncology Clinical Trials Combination Therapies Metabolic Disorders Z944 (Ulixacaltamide) Pharmaceutical Collaboration

McMaster Scientists Discover Manikomycin, a New Antibiotic Candidate

It binds the ribosomal E-site to block tRNA translocation, creating a route to overcome existing antibiotic resistance.

Oral GLP-1 Weight-Loss Pills Curb Hedonic Eating by Hitting Deep-Brain Circuit in Mice

Five-Target ‘Trojan Horse’ Drug Outperforms Leading Incretins in Obese Diabetic Mice

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Liverpool Researchers Report Novltex, a Synthetic Antibiotic Class Against Multidrug-Resistant Bacteria

Autism-Like Behaviors in Mice Traced to Thalamic Circuit as Epilepsy Drug Candidate Reverses Signs